Exchange: NASDAQ·Updated 05:06 PM EDT
INDV logo

INDV Indivior Plc

$35.00
$0.90
(2.66%)
Today
Closed $34.77
$0.23
(0.66%)
After Hours
EarningsOct 29
Mkt Cap$4B
Vol1.92M

About INDV

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.
39

Bearish Sentiment

How do you feel about INDV?

Merlintrader
Latest company news, October 19, 2026: Indivior will report Q3 results on October 29 at 7:00 a.m. ET. Shareholders of Indivior and Supernus approved the merger on October 15; closing is expected November 2, per company statements. Indivior $INDV: SUBLOCADE, Supernus Merger And Dividend Deeper dive in our hub. Not investment advice.

Advertisement|Remove ads.